EXPOSED
The modal pharmacist is a community/retail pharmacist whose day is dominated by prescription verification, insurance adjudication, drug-interaction screening, and inventory work — all rule-based screen tasks that software already does well, with robotic dispensing cabinets handling the counting. What holds the job up is regulatory: state law requires a licensed pharmacist to sign off on dispensing, and that pharmacist is personally liable for errors, plus immunizations, compounding, and patient counseling need a body behind the counter. Clinical and hospital pharmacists (rounding, TPN dosing, antimicrobial stewardship) sit in a meaningfully safer tier than the retail median scored here.
Roughly flat across the period, with year-to-year wobble.
Median pay $128,090 → $140,910 -12.0% in real terms
This line is counted by the Bureau of Labor Statistics — the one figure on this page that isn't a judgement of ours. Headcount moves on demand, offshoring, demographics and the business cycle, and automation is one term among several, often not the loudest.
So a falling line is not evidence that AI did it, and a rising one is not evidence that it won't. Both happen in this register: some occupations resist automation and shrink anyway, others are highly automatable and keep growing. The marked year is 2020.
BLS projection, 2024–2034
+4.6% 335,100 → 350,500 on the projections basis
Growing, and only partly exposed
The BLS expects +4.6% more of these jobs by 2034, and at 61/100 the work is only partly exposed — some tasks are automatable, the core of the job is not. Nothing here is in tension.
Different clocks. The score is what current AI could do to this work today. The projection is how many of these jobs will exist in 2034. Everything between the two — how fast employers actually adopt, whether demand grows in the meantime — is why they can point opposite ways without either being wrong.
~14,200 openings a year on average, including replacing people who leave.
DruggistApothecaryPharmacistPrescriptionistRadiopharmacistFloat PharmacistPharmacy ResidentRetail PharmacistTravel PharmacistClinical PharmacistHospital PharmacistPharmacy ConsultantPharmacy CoordinatorIndustrial PharmacistOutpatient PharmacistRegistered PharmacistInformatics PharmacistPharmacy InformaticistPharm D (Pharmacy Doctor)Pharmacist in Charge (PIC)Pharmacy Operations ManagerDistrict Pharmacy SupervisorPharmacy Services Clinical Coordinator
Holding it up: liability shield . Weakest point: task resistance .
Mixed — a routine tier and a judgment tier DUR screening, refill authorization, and third-party claim rejections are already resolved by algorithm in most chain systems — what keeps this at 9 rather than 4 is the residual that software cannot close out: sterile and non-sterile compounding to USP 795/797, administering vaccines, counseling on inhaler and insulin pen technique, and the judgment calls on early refills and controlled-substance red flags under PMP review.
Some physical or field component You are on your feet behind a counter for a ten-hour shift giving IM injections, checking the physical drug against the NDC on the stock bottle, mixing suspensions, and handling CII inventory in a locked safe — but it is one climate-controlled room with the products delivered to you, which is why this lands at 10 and not with home health or EMS.
Licensed human required and personally liable Every state board requires a pharmacist-in-charge whose licence number is on the dispensing record, and corresponding responsibility doctrine means you personally answer for a filled prescription regardless of what the technician or the software did — DEA registration, board discipline, and named-defendant status in a wrong-drug suit all attach to your licence, not the store's.
Meaningful discretion Refusing a fill on a suspicious opioid script, calling a prescriber about a QT-prolonging combination, or deciding a therapeutic substitution under protocol are genuine discretionary calls you own — but they sit inside prescriber-set therapy and state formulary rules, so you are the check on someone else's decision rather than the one making the diagnosis, which caps this at 12.
The verdict above describes this occupation as a whole. Almost nobody does the typical version of a job — tick what's actually in your week and see how your own mix sits.
Your task mix speaks to task resistance (9/20 here) — how much of the day's work current AI already does. That is the dimension the boxes above are about.
It cannot move the other three. Liability shield (18/20) is whether the law requires a licensed human to sign. Trust premium (12/20) is whether buyers specifically pay for a person. Judgment and accountability (12/20) is whether the role exists to own consequential calls. Those are facts about the occupation's standing, not about which tasks are in your week — a paralegal who does only trial exhibits still holds no licence. Together they are 42 of this occupation's 61 points (69%).
Embodiment (10/20) is also a property of the work rather than the worker, but we don't tag individual tasks as physical or not, so the picker can't tell you anything about it. That's a limit of this tool, not a claim.
Did we get the list right? Tell us what's missing — the tasks are written from the outside, and you're reading this from the inside.
Physician Assistants SAFE
The moves above are yours to make. This is the other half: what would have to change in the world for the occupation itself to score higher. None of it is in any one person's gift, but it is where the floor actually comes from. Scores here are not a one-way ratchet. Only two of the five dimensions — task resistance and embodiment — track what machines can do. The other three track law, what buyers will pay for, and who is answerable, and those move in both directions, often in response to the same pressure AI creates. If every lever below landed, this occupation would score around 73/100 — SAFE.
Provider-status expansion: pharmacists billing under state collaborative practice agreements and 'test-and-treat' authority (flu/strep/COVID prescribing, hormonal contraception, PrEP — already law in Idaho, California, Colorado and others) makes the pharmacist the named prescriber who owns the diagnostic call and its consequences, not a checker of someone else's order. Federal pharmacist provider status under Medicare Part B would generalize it.
Task-mix shift is genuine here: retail pharmacy has a routine tier (fill verification, adjudication, inventory) and a judgment tier (polypharmacy deprescribing in elderly patients, renal/hepatic dosing, opioid red-flag refusal-to-fill decisions, DEA corresponding-responsibility calls). If central fill and automated adjudication absorb the routine tier — the direction Amazon Pharmacy, mail-order, and hub-and-spoke models are already going — the remaining role is largely the judgment tier. This raises resistance per surviving job while reducing headcount.
State boards of pharmacy explicitly extending the personal-verification requirement to AI outputs — e.g. a rule (as several boards have debated for tech-check-tech and remote verification programs) that a pharmacist must personally countersign any algorithmically generated dose adjustment or interaction override, and that AI-assisted verification does not discharge the pharmacist's duty of care. Conversely, states expanding technician product verification or fully remote/central-fill verification ratios would push this down.
Growth in on-site services that require a licensed body: point-of-care testing, long-acting injectable administration, sterile and non-sterile compounding under USP 795/797 (a niche that expanded after the 2023 GLP-1 shortage compounding wave). Immunization authority under the PREP Act declaration being made permanent in state law would keep this anchored.
Narrow route only: independent and specialty pharmacies where patients or self-insured employers pay for named-pharmacist medication therapy management, plus concierge/long-term-care consultant pharmacy contracts. This does not extend to the retail chain median, where the buyer is a PBM and the patient chooses on copay and location.
The limit. The liability shield is already near maximum and is the whole load-bearing structure — there is little headroom above 18, and the realistic risk is it falling as boards approve technician verification and remote/central fill. Trust premium is structurally capped because the paying party is a PBM, not the patient. Even with every lever, the retail median stays exposed; the durable gains accrue to clinical, ambulatory-care, and prescribing-authority roles, which is a different job with fewer seats.
| New York-Newark-Jersey City, NY-NJ | 20,000 | $141,320 +0% |
| Los Angeles-Long Beach-Anaheim, CA | 12,450 | $157,440 +12% |
| Chicago-Naperville-Elgin, IL-IN | 8,930 | $140,880 +0% |
| Dallas-Fort Worth-Arlington, TX | 7,230 | $138,170 -2% |
| Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 6,460 | $148,740 +6% |
| Houston-Pasadena-The Woodlands, TX | 6,410 | $140,470 +0% |
| Miami-Fort Lauderdale-West Palm Beach, FL | 6,150 | $135,210 -4% |
| Atlanta-Sandy Springs-Roswell, GA | 6,120 | $139,870 -1% |
| Napa, CA | 180 | $200,580 +42% |
| San Jose-Sunnyvale-Santa Clara, CA | 1,960 | $199,040 +41% |
| San Francisco-Oakland-Fremont, CA | 3,670 | $177,410 +26% |
Carle Health · NHS · National University Health System · Taupō pharmacy · Walgreens · Taiwan hospital · Tugun Satellite Hospital · Mayo Clinic · Hamilton Health Sciences · Queen's Medical Centre, Nottingham University Hospitals NHS Trust · Cone Health · Singapore hospitals · Rader Health Clinic
Healthcare IT News reports that Singapore's National University Health System has adopted an AI system for pharmacy operations expected to save 850 staff hours per week.
A report describes the opening of what is billed as the EU's first fully unstaffed automated pharmacy, operating without pharmacy counter staff or queues.
Pharmacy Business reports the NHS plans to introduce an AI tool developed with Microsoft intended to reduce administrative workload for clinical staff.
The General Pharmaceutical Council issued guidance stating pharmacists must apply professional judgement when using AI tools in practice.
The General Pharmaceutical Council published a position statement setting out expectations for the use of AI in pharmacy practice, as reported by Chemist+Druggist.
PharmacyToday reports that an AI-driven dispensing robot has been installed at a pharmacy in Taupō, New Zealand, described as the first of its kind there.
Has AI actually changed your work? One tap, anonymous, and the running tally is public. Nothing else is asked of you.
Rather than check back: get the digest and we'll tell you what changed — or watch a single occupation from its own page.